Alphabet (GOOGL) slips after hours despite Street-beating Q2 >>> READ MORE

CERS CRIS CGEN CPHD – 4 Fab Biotech Stocks on the Fast Track

Continued upside potential for this sector

      View All  


Compugen (CGEN) is the world leader in identification of proteins and other cellular matter that can be used as markets for disease, giving drug companies identifiable targets for research. Its technology and databases replace the hit-and-miss approach found in most R&D efforts and also produces patented information and markers the company can license or use for internal development efforts. Internally the company is developing therapeutic proteins and monoclonal antibodies for use against immunological disorders and cancer. Compugen has a large universe of clients among big and small drug development companies.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC